What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 5 minute read Healthcare Industry News Is Strive, Inc.’s bitcoin accumulation paying off? Q3 2025 results reveal major GAAP loss and Semler Scientific merger plans Strive, Inc.’s Q3 2025 results show a $192M GAAP loss, major bitcoin accumulation, and a Semler Scientific merger plan. Find out what the strategy means for investors. bySoujanya RaviNovember 16, 2025